FDA Cosmetics Regulations Workshop

Thank you!

The 2022 Workshop was the most highly attended IBA FDA Cosmetics Regulations Workshop in event history.

Please join us again in 2023! More information coming soon.

In 1983, IBA was chosen by the Food and Drug Administration to create the FDA Cosmetics Regulations Workshop because of its focus on small and mid-sized cosmetic entrepreneurial companies. Government officials and industry experts offer information to help beauty companies comply with regulations.

This two-day event features expert speakers who will learn in-depth about the cosmetic and personal care products industry’s latest issues. These updates include U.S. FDA activities, changes in over-the-counter drug regulations, FDA warning letters and consumer class actions, FTC, NAD, advertising claims and testing, and how to protect your business.

A ‘must-attend’ for anyone responsible for developing, testing, and marketing beauty, personal care, and wellness products.

On-Demand Disclaimer: Important note, the Day 1 session presented by FDA is not permitted to be recorded and will only be available live. The FDA presentations will not be available on-demand. Please plan accordingly! All other presentations will be recorded and available on-demand for registered attendees.

2022 Agenda

Day 1, September 21, 2022

12:00 – 12:15 pm ET	Welcome Donald Frey, President & CEO, IBA Craig Weiss, IBA Technical/Regulatory Committee Chair & President, Consumer Product Testing Company
12:15 – 1:15 pm ET	Current U.S. FDA Cosmetics Developments Linda Katz, M.D., M.P.H., Director, Office of Cosmetics & Colors, Center for Food Safety and Applied Nutrition (CFSAN), FDA
1:15 – 1:30 pm ET	BREAK – Sponsored by CIS
1:30 – 2:30 pm ET	Current U.S. OTC Drug Monograph Developments Steven Adah, Ph.D., Associate Director of Monograph, Division of Nonprescription Drug Products, Center for Drug Evaluation and Research (CDER), FDA
2:30 – 2:45 pm ET	BREAK
2:45 – 3:45 pm ET	OMUFA Update Captain Matt Brancazio, Pharm.D., MBA, RAC, CAPT, USPHS, Branch Chief, Policy and Operations Branch, Division of User Fee Management, Office of Management, Center for Drug Evaluation and Research (CDER), FDA
3:45 – 4:00 pm ET	BREAK
4:00 – 5:00 pm ET	FTC Updates: .com Disclosures Update, Endorsement Guide Update, Green Guides Update Angela Diesch, Partner, Amin Talati Wasserman LLP
5:00 – 5:15 pm ET	Closing & Adjournment to Day 2 Donald Frey, President & CEO, IBA Craig Weiss, IBA Technical/Regulatory Committee Chair & President, Consumer Product Testing Company

Day 2, September 22, 2022

12:00 – 12:15 pm ET	Welcome Donald Frey, President & CEO, IBA Craig Weiss, IBA Technical/Regulatory Committee Chair & President, Consumer Product Testing Company
12:15 – 1:15 pm ET	PFAS Update & Class Action Michael J. Duvall, Partner, Dentons US LLP Chanell Botshekan, Associate, Dentons US LLP
1:15 – 1:30 pm ET	BREAK
1:30 – 2:30 pm ET	California Update: CFFIRKA, CARB, Prop 65 Peter Duchesneau, Partner, Manatt, Phelps & Phillips, LLP
2:30 – 2:45 pm ET	BREAK
2:45 – 3:45 pm ET	International Regulatory Hot Topics Karen Yarussi-King, IBA Technical/Regulatory Committee Co-Chair & Principal, Global Regulatory Associates
3:45 – 4:00 pm ET	BREAK
4:00– 5:00 pm ET	1,4-Dioxane Deep Dive Arielle Brown, Senior Manager, Government Affairs, The American Cleaning InstituteKathleen Stanton, Associate Vice President, Technical & International Affairs, The American Cleaning Institute
5:00 – 5:15 pm ET	Closing & Workshop Adjournment Donald Frey, President & CEO, IBA Craig Weiss, IBA Technical/Regulatory Committee Chair & President, Consumer Product Testing Company